Dr. Wolfgang Plischke is Chairman-Supervisory Board at Evotec AG, Council Member at University of Hohenheim, Chairman-Supervisory Board at Bayer Innovation GmbH, Chairman-Supervisory Board at Bayer Real Estate GmbH, Chairman-Supervisory Board at Bayer Technology Services GmbH, a Member at Helmholtz-Gemeinschaft Deutscher Forschungszentren eV, Member-Executive Board at Bundesverband der Deutschen Industrie e.V., Member-Executive Board at German Asia Pacific Business Association, Member-Executive Board at Robert Koch Stiftung eV, Member-Executive Board at Walter Siegenthaler Gesellschaft and Vice President at European Chemical Industry Council.
He is on the Board of Directors at Bayer AG, German Chemical Industry Fund and Paul Ehrlich-Foundation. Dr. Plischke was previously employed as Chairman-Management Board by Bayer HealthCare AG, Independent Non-Executive Director by Ark Therapeutics Group Plc, Member-Management Board by Bayer AG, President by Bayer Yakuhin Ltd., Head-Marketing by Bayer Schering Pharma AG, Chairman-Supervisory Board by Covestro AG, and Chairman by Verband Forschender Arzneimittelhersteller e.V.
He also served on the board at Ludwig Heilmeyer Society.
He received his undergraduate degree from the University of Hohenheim.